The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS

NCT04391361 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Respiratory Function
Scopolamine

Interventions

DRUG: Scopolamine, atropine, edaravone and dexmedetomidine
DRUG: Edaravone

Sponsor

Ruijin Hospital